Tetsuyoshi Kawakami

1PUBLICATIONS
4CO-AUTHORS
Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 29, 2019
A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors.

Toshihiko Doi, Kei Muro, Hiroshi Ishii

Pageof 1

Frequent Collaborators

1 joint publications

Hiroshi Ishii

1 joint publications

Kazuto Gemmoto

1 joint publications

Hiroyoshi Nishikawa

1 joint publications

Noboru Yamamoto